Michael Lang
Nurse Practitioner · New Milford, NJNPI 1205203155
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 201 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,641 and has fallen 56.2% since, to $1,157 in 2025. Among nurse practitioner clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$439
- E.r. Squibb & Sons, L.L.C.$374
- Novartis$344
- Taiho Oncology, Inc.$241
- Eisai Inc.$222
- AstraZeneca$204
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,91398%
- Education$702%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 22 | $439 |
| E.r. Squibb & Sons, L.L.C. | 22 | $374 |
| Novartis | 25 | $344 |
| Taiho Oncology, Inc. | 12 | $241 |
| Eisai Inc. | 17 | $222 |
| AstraZeneca(2 entities) | 11 | $204 |
| Astellas Pharma US Inc | 8 | $203 |
| AbbVie | 6 | $193 |
| Johnson & Johnson | 10 | $169 |
| Bayer | 7 | $160 |
| Daiichi Sankyo Inc. | 8 | $150 |
| Regeneron Healthcare Solutions, Inc. | 2 | $149 |
| GSK | 7 | $139 |
| Rigel Pharmaceuticals, Inc. | 7 | $137 |
| Karyopharm Therapeutics Inc. | 1 | $124 |
| Apellis Pharmaceuticals, Inc. | 6 | $103 |
| AVEO Pharmaceuticals, Inc. | 4 | $100 |
| Lilly USA, LLC | 5 | $83 |
| EMD Serono, Inc. | 5 | $77 |
| Route 92 Medical, Inc. | 1 | $73 |
| Mirati Therapeutics, Inc. | 3 | $60 |
| Pharmacosmos Therapeutics Inc. | 3 | $56 |
| Array Biopharma Inc | 2 | $34 |
| Boston Scientific | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Incyte Corporation | 1 | $22 |
| Tempus AI, Inc | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $18 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,983 in reported general payments places this provider in the 90th percentile of 2,138 nurse practitioner providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZarxioFilgrastim-Sndz | 12 | $21,543 |
| Anastrozole | 51 | $774 |
| Ondansetron Hcl | 16 | $161 |
| Prednisone | 24 | $57 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in New Milford
- Nancy BonnetMorristown$407K
- Vanessa CoppolaCloster$205K
- Olufunmilayo IloriUnion$133K
- Janice BeitzHaddon Heights$75K
- Adewale AdefowojuUnion$70K
- Sophia KimEnglewood$70K
- Elizabeth FletcherCamden$62K
- Lannae EwingLinwood$39K
- Beth SavageNew Brunswick$34K
- Tina OcchiutoMorristown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.